Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?

Leuk Lymphoma. 2018 Jul;59(7):1753-1755. doi: 10.1080/10428194.2017.1393666. Epub 2017 Oct 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biopsy
  • Female
  • Humans
  • Immunohistochemistry
  • Immunophenotyping
  • Plasmablastic Lymphoma / diagnosis*
  • Plasmablastic Lymphoma / immunology
  • Plasmablastic Lymphoma / therapy
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / immunology
  • Skin Neoplasms / therapy
  • Treatment Outcome